October 15 & WORKSHOP ON DRUG DISCOVERY AND INFECTIOUS DISEASE. IMéRA, Maison des astronomes, Marseille

Save this PDF as:
 WORD  PNG  TXT  JPG

Size: px
Start display at page:

Download "October 15 & WORKSHOP ON DRUG DISCOVERY AND INFECTIOUS DISEASE. IMéRA, Maison des astronomes, Marseille"

Transcription

1 October 15 & WORKSHOP ON DRUG DISCOVERY AND INFECTIOUS DISEASE IMéRA, Maison des astronomes, Marseille Organizing committee Philippe HALFON Hôpital Européen, laboratoire Alphabio, service maladies infectieuses, Marseille ; Marc BOURLIERE Head of Department of Hepato-Gastro-enterology, Hopital Saint-Joseph, Marseille ; Speakers Tarik ASSELAH Professor of Medicine, service d hépatologie & Head of Viral Hepatitis INSERM UMR1149, Hôpital Beaujon, AP-HP Pierre BEDOSSA Professor of Pathologie, service d anatomo-pathologique, Hôpital Beaujon, AP-HP Marc BOURLIERE Head of Department of Hepato-Gastro-enterology, Hopital Saint-Joseph, Marseille Jacques BELGHITI Professor of Surgery, Haute Autorité de Santé Philippe HALFON Hôpital Européen, laboratoire Alphabio, service maladies infectieuses, Marseille Raymond SCHINAZI Veterans Affairs Medical Center, Atlanta, Georgia, USA. Eric VIVIER Director, Centre d'immunologie de Marseille-Luminy ; Professor of Immunology, Marseille Medical School

2 Thursday 15 October h30-15h40 First Session: Chairs: 15h40-16H10 Introduction: Philippe Halfon Hepatitis B and Philipe Halfon Hepatitis B: current therapy Tarik Asselah 16H10-16H40 Perspectives for an HBV cure Raymond Schinazi 16H40-17H10 Viral resistance: will it be an issue? Philippe Halfon 17h10-17h30 Round Table Friday 16 October 2015 Second session: Perspectives in Therapeutics Chairs: 09H30-10h00 10h00-10H30 Tarik Asselah and Philippe Halfon Cancer Immune-therapy Eric Vivier Cancer stem cells therapy Philippe Halfon 10H30-11h00 HCV drug discovery Raymond Schinazi 11h00-11h30 Third session : Chairs 14h30-15h00 15H00-15H30 15H30-16H00 16h00-16h20 Round Table Future perspectives for liver diseases Liver transplantation : Perspectives Jacques Belghiti HCV future clinical trials Round table Conclusion and Take home messages

3 Organizing committee Dr. Philippe HALFON: Head of Infectious diseases in Hospital Europeen and head of the Virological department Alphabio laboratory, Marseilles, and. He is appointed as Professor of Medicine at Paris Medical College. He received hispharmd degree in 1985 from the University of Marseilles and completed training Virology in Saint Louis Hospital and Institute Pasteur in Paris. He received his PhD degree in 1993 and post-doctoral training in Virology at McGill University, Montreal, Canada. He received is MD degree from the University of Marseilles and completed training as Infectious Diseases. He has published over 250 peer-reviewed papers and 3 books, and holds 4US patents. Pr Halfon is the founder of several biotechnology companies focusing on antiviral drug discovery and development, and is currently developing one drug in HCV and two innovative drugs in treatment of cancer stem cells. Pr Halfon received award of Tremplin in the Sénat-France France. Dr. Halfon is member on scientist societies and French Agency against AIDS and European Expert for Institutional agency., received his medical degree in 1987 from Marseilles University in Marseile, France. He completed his fellowship training at Marseilles University hospital and in Beaujon University hospital in Paris. He was assistant in Hepatology in Conception University hospital in Marseilles before taking up his current position as head of the Hepato- Gastroenterology department at Hospital Saint Joseph also in Marseilles. Dr Bourlière and his group have participated in hepatitis B and C and HCC clinical trials; His current research focus is the use and development of non invasive biomarkers in hepatitis and the development of new antiviral therapy for hepatitis C. Dr Bourlière has published more than 200 papers or chapters in international journals and books focused on hepatitis B and C. As well as reviewing for many specialist journals, he has served as member of the editorial board of Gastroenterologie, Clinique et Biologique. Dr Bourlière belongs to the French Agency for AIDS and hepatitis research (ANRS) and he heads the ANRS group that coordinates hepatitis clinical therapeutic trials (AC24). He co chair the ANRS group that coordinates hepatitis clinical trial in co infected patients (AC5-24). He belonged to the scientific committee of the HEPATHER cohort. He is also member of several professional societies including the French and European associations for the study of the liver.

4 Speakers Tarik Asselah is a Professor of Medicine and Hepatology at Hôpital Beaujon, Clichy, France, and at the University Paris Diderot, France. He has a medical degree in gastroenterology hepatology and also holds a PhD in virology. Professor Asselah s fields of research include natural history of chronic hepatitis B and C (HCV virology, fibrogenesis, insulin resistance) and clinical trials on new molecules. He also works on gene expression and HCV infection, implications in fibrosis progression and response to treatment. Professor Asselah leads a research group on viral hepatitis at INSERM (UMR 1149, Centre de Recherche sur l Inflammation). He has a particular interest in the treatment of HBV and HCV with new direct-acting antivirals. He has been involved as a principal investigator in several clinical trials of direct-acting antiviral agents for HCV. Professor Asselah is a member of EASL and an expert for the French National Agency for Research on AIDS and Viral Hepatitis (ANRS). He has published more than 170 articles in the field of viral hepatitis with numerous original articles, book chapters and reviews in peerreviewed journals, including Gastroenterology, Hepatology, Blood, Gut and Journal of Hepatology (H-index = 45). Professor Asselah was selected as a rising star in gastroenterology in 2009 by the UEG. He received a prize for his genomic studies on HCV in 2005 from the French Association for the Study of the Liver. Professor Belghiti was born in Casablanca, Morocco in He graduated from the University of Medicine, Paris in 1974, qualified as a surgeon in 1980 and became a Professor of Surgery in He was the Head of the HepatoBilioPancreatic Surgery and Liver Transplantation department in Beaujon Hospital, University of Paris, for 20 years, until In addition Professor Belghiti is the author of more than 70 book chapters and is co-editor of the highly acclaimed specialty reference book, Surgery of the Liver, Biliary Tract and Pancreas edited by Blumgart. In 2014 he was nominated by the President of France to the board of the High Authority for Health, where he chairs the evaluation committee of medical devices. He was recently appointed head of the selection committee for innovative devices. Several associations have benefitted from Professor Belghiti s expertise including as chairman of the scientific committee of the IHPBA, president of E-AHPBA and president of the ILTS (International Liver Transplantation Society). He was responsible for the organisation of the ILTS World Congress in Paris in 2008, as well as the 10th World Congress of the IHPBA in Paris.

5 Dr. Raymond F. Schinazi is the Frances Winship Walters Professor of Pediatrics and director of the Laboratory of Biochemical Pharmacology at Emory University. He serves as senior research career scientist at the Atlanta Department of Veterans Affairs and director of the Scientific Working Group on Viral Eradication for the NIH-sponsored Emory University Center for AIDS Research (CFAR). Dr. Schinazi received his D.Sc. (1972) and Ph.D. (1976) in chemistry from the University of Bath, England. He has authored over 500 peer-reviewed papers and seven books and holds 92 issued U.S. patents and over 120 non-u.s. national stage patents and patent applications, which have resulted in 12 New Drug Applications. A world leader in nucleoside chemistry, Dr. Schinazi is best known for his pioneering work on HIV and hepatitis C virus (HCV) drugs d4t (stavudine), 3TC (lamivudine), FTC (emtricitabine/emtriva), LdT (telbivudine) and most recently sofosbuvir (Sovaldi), which are now approved by the FDA. He is also the founder of five biotechnology companies, including Pharmasset, Inc. More than 94 percent of HIVinfected individuals in the U.S. on combination therapy take at least one of the drugs he invented, and it is estimated that his work has saved more than three million lives worldwide. Dr. Schinazi served on the Presidential Commission on AIDS and is the recipient of numerous awards, including the 2006 Distinguished Scientist Award from the Hepatitis B Foundation, the Friends of the National Library of Medicine 2013 Distinguished Medical Science Award, the SCRIP 100 Leaders Award in 2014, and the Emory University s 175 History Makers. Dr. Schinazi is internationally recognized as one of the most influential persons in the life science sector. Eric Vivier was trained as a Doctor in Veterinary Medicine and as a PhD in Immunology in Paris. He completed his postdoctoral work at Harvard. He is currently the Director of the Centre d Immunologie de Marseille-Luminy, where he heads the laboratory of «Natural Killer cells and Innate Immunity». He is a Professor at the Marseille Medical School and a Scholar at the Institut Universitaire de France. His work focuses on Natural Killer cells and Innate Lymphoid cells. He is co-founder of Innate-Pharma where he is collaborating to set-up NK cell-based therapies against cancer, such as the anti-kir and anti-nkg2a mabs. Eric Vivier has been elected to the French National Academy of Medicine in 2013 and received several awards including the EFIS Award and the Grand Prix Turpin in Oncology from the French National Academy of Science.

Universal HCV treatment: Strategies for simplification

Universal HCV treatment: Strategies for simplification Universal HCV treatment: Strategies for simplification PARIS HEPATOLOGY CONFERENCE 3 January 217 Tarik Asselah (MD, PhD) Hepatology & Chief INSERM UMR 1149, Hôpital Beaujon, Clichy, France. Disclosures

More information

Research in viral hepatitis: the French ANRS experience

Research in viral hepatitis: the French ANRS experience PARIS HEPATITIS CONFERENCE January 14-15, 2013 Research in viral hepatitis: the French ANRS experience Pr. Jean-François DELFRAISSY Director of ANRS Internal Medicine Department CHU Bicêtre Paris XI -

More information

IFN-free therapy in naïve HCV GT1 patients

IFN-free therapy in naïve HCV GT1 patients IFN-free therapy in naïve HCV GT1 patients Paris Hepatitis Conference Paris, 12th January, 2015 Pr Tarik Asselah MD, PhD; Service d Hépatologie & INSERM U773 University Paris Diderot, Hôpital Beaujon,

More information

Fellowship Program Director: Dr. Annette Granich

Fellowship Program Director: Dr. Annette Granich Consultation-Liaison Psychiatry Fellowship Name of institution: McGill University Health Center Type of Fellowship: Consultation-Liaison Psychiatry Number of fellowship positions requested: 1-2 Duration

More information

Theodor Bilharz Research Institute

Theodor Bilharz Research Institute Theodor Bilharz Research Institute The Ninth Annual Scientific Conference on Hepatogastroenterology Theodor Bilharz Research Institute in collaboration with Beaujon Hospital - France Sunday March 5 th,

More information

COUNCIL. Executive Committee. President Jan Lerut, MD, PhD. President-Elect Michael Charlton, MD. Secretary John R.

COUNCIL. Executive Committee. President Jan Lerut, MD, PhD. President-Elect Michael Charlton, MD. Secretary John R. 1 2015-2016 COUNCIL Executive Committee President Jan Lerut, MD, PhD President-Elect Michael Charlton, MD Secretary John R. Klinck, MD Treasurer Patrizia Burra, MD, PhD Past-President Elizabeth A. Pomfret,

More information

Professor J. Peter A. Lodge MD FRCS FEBS

Professor J. Peter A. Lodge MD FRCS FEBS Professor J. Peter A. Lodge MD FRCS FEBS Full name: Address: Email: Jeremy Peter Alan Lodge HPB and Transplant Unit St James's University Hospital Leeds LS9 7TF, UK peter.lodge@nhs.net Telephone: Secretary

More information

The International Coalition to Eliminate Hepatitis B.

The International Coalition to Eliminate Hepatitis B. The International Coalition to Eliminate Hepatitis B. HBV is currently incurable However functional cure (HBsAg seroclearance) is observed in a small number of patients, either spontaneously or in the

More information

Follow-up of patients with SVR Lawrence Serfaty Service d Hépatologie, UMR_S 938 Hôpital Saint-Antoine Université Pierre&Marie Curie Paris, France

Follow-up of patients with SVR Lawrence Serfaty Service d Hépatologie, UMR_S 938 Hôpital Saint-Antoine Université Pierre&Marie Curie Paris, France 9th Paris Hepatitis Conference, January 11-12, 2016 Follow-up of patients with SVR Lawrence Serfaty Service d Hépatologie, UMR_S 938 Hôpital Saint-Antoine Université Pierre&Marie Curie Paris, France Disclosures

More information

Forward Looking Statements

Forward Looking Statements Antiviral Therapies Forward Looking Statements This presentation contains forward-looking statements, including the timing of our drug development programs. Risks include delays in manufacturing created

More information

HEMATOLOGY AND ONCOLOGY

HEMATOLOGY AND ONCOLOGY x THE POWER OF HEMATOLOGY AND ONCOLOGY Experts. Experience. Execution. A Deeper Dive into Hematology and Oncology Medpace supports our sponsors who are advancing new anti-cancer therapies by providing

More information

Accepted Manuscript. International Hepatology

Accepted Manuscript. International Hepatology Accepted Manuscript International Hepatology HCV cirrhosis at the edge of decompensation: Will ABT-450/r, ombitasvir, dasabuvir and ribavirin solve the need for treatment? Tarik Asselah, Savino Bruno,

More information

DIVISION OF NEPHROLOGY

DIVISION OF NEPHROLOGY The Division s funding from the NIH has increased from $3.7 Million in 2001 to over $11 Million in 2006. DIVISION OF NEPHROLOGY DR. BARBARA MURPHY was voted President-Elect of the American Society of Transplantation

More information

Hepatitis B Cure: from discovery to regulatory endpoints in HBV clinical research A summary of the AASLD/EASL statement

Hepatitis B Cure: from discovery to regulatory endpoints in HBV clinical research A summary of the AASLD/EASL statement Hepatitis B Cure: from discovery to regulatory endpoints in HBV clinical research A summary of the AASLD/EASL statement Fabien Zoulim Service d hépatologie, Hospices Civils de Lyon INSERM U1052, Cancer

More information

KIDNEY LIVER MEETS FINAL PROGRAM KIDNEY MEETS LIVER. When the excellence in renal and liver medicine come together. XXXXXXX

KIDNEY LIVER MEETS FINAL PROGRAM KIDNEY MEETS LIVER. When the excellence in renal and liver medicine come together. XXXXXXX XXXXXXX When the excellence in renal and liver medicine come together. 1 COMITATI SCIENTIFIC PROGRAM Organizing Committee Prof. Michel Jadoul Chief Service de Nephrologie Clinique Universitaire Saint-Luc

More information

Chronic viral hepatitis and liver disease in Belgium Pierre Deltenre

Chronic viral hepatitis and liver disease in Belgium Pierre Deltenre Chronic viral hepatitis and liver disease in Belgium Pierre Deltenre Brussels, November 7, 2017 Hepatitis B and C in Belgium What we need to know 1. Who is at risk of infection? 2. What is the natural

More information

COUNCIL. Executive Committee. President Elizabeth A. Pomfret, MD, PhD. President-Elect Jan Lerut, MD, PhD. Secretary Michael Charlton, MD

COUNCIL. Executive Committee. President Elizabeth A. Pomfret, MD, PhD. President-Elect Jan Lerut, MD, PhD. Secretary Michael Charlton, MD 2014-2015 COUNCIL Executive Committee President Elizabeth A. Pomfret, MD, PhD President-Elect Jan Lerut, MD, PhD Secretary Michael Charlton, MD Treasurer Patrizia Burra, MD, PhD Past-President Didier Samuel,

More information

Bruce A. Beutler and Jules A. Hoffmann. Ralph M. Steinman

Bruce A. Beutler and Jules A. Hoffmann. Ralph M. Steinman PRESS RELEASE 20-0-03 The Nobel Assembly at Karolinska Institutet has today decided that The 20 Nobel Prize in Physiology or Medicine shall be divided, with one half jointly to Bruce A. Beutler and Jules

More information

@PremierHA #AdvisorLive. Download today s slides at

@PremierHA #AdvisorLive. Download today s slides at @PremierHA #AdvisorLive Download today s slides at www.premierinc.com/events Logistics Audio Use your computer speakers or dial in with the number on your screen Notes Download today s slides from the

More information

SPONSORSHIP AND AD OPPORTUNITIES

SPONSORSHIP AND AD OPPORTUNITIES to benefit the American Association for Cancer Research Foundation October 22, 2017 Hilton Philadelphia at Penn s Landing // 201 South Columbus Boulevard // Philadelphia, PA SPONSORSHIP AND AD OPPORTUNITIES

More information

BEAUTIFUL Executive Committee

BEAUTIFUL Executive Committee BEAUTIFUL Executive Committee Kim FOX Co-Chairman of the Executive Committee Professor of Clinical Cardiology at the Royal Brompton Hospital Honorary Consultant Cardiologist, Chelsea and Westminster Hospital

More information

Worldwide Causes of HCC

Worldwide Causes of HCC Approach to HCV Treatment in Patients with HCC JORGE L. HERRERA, MD, MACG UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE Worldwide Causes of HCC 60% 50% 40% 54% 30% 20% 10% 31% 15% 0% Hepatitis B Hepatitis

More information

HCV eradication with direct acting antivirals (DAAs)?

HCV eradication with direct acting antivirals (DAAs)? HCV eradication with direct acting antivirals (DAAs)? Emilie Estrabaud Service d Hépatologie et INSERM UMR1149, AP-HP Hôpital Beaujon, Paris, France. emilie.estrabaud@inserm.fr HCV eradication with direct

More information

RIC-Mel Network - Network for Research and Clinical Investigation on Melanoma - French national cohort of

RIC-Mel Network - Network for Research and Clinical Investigation on Melanoma - French national cohort of RIC-Mel Network - Network for Research and Clinical Investigation on Melanoma - French national cohort of melanoma patients Head : Pr Dreno Brigitte, INSERM Unité U892 Equipe 2 «Recherche clinique et translationnelle

More information

2016 ADHD Conference Speaker Biographies

2016 ADHD Conference Speaker Biographies 2016 ADHD Conference Speaker Biographies Dr. Rosemary Tannock, PhD Rosemary Tannock is now Professor Emerita at the University of Toronto and continues as a Senior Scientist at the Hospital for Sick Children

More information

PENN TRANSPLANT SURGERY FACULTY

PENN TRANSPLANT SURGERY FACULTY Abraham Shaked, MD, PhD, is the Eldrige L. Eliason Professor of Surgery, and Director of the Penn Transplant Institute. Dr. Shaked received his MD degree from the Hebrew University in Israel and completed

More information

PROGRAM BOOK. Best Practice Sharing: Tested nutritional solutions to support mobility and recovery. The 36th ESPEN Congress Geneva, Switzerland

PROGRAM BOOK. Best Practice Sharing: Tested nutritional solutions to support mobility and recovery. The 36th ESPEN Congress Geneva, Switzerland PROGRAM BOOK Best Practice Sharing: Tested nutritional solutions to support mobility and recovery The 36th ESPEN Congress Geneva, Switzerland Saturday, September 6, 2014 12:00-13:30 Geneva Convention Centre

More information

HBV quantitative sag assay: Ready for Prime time? yes

HBV quantitative sag assay: Ready for Prime time? yes HBV quantitative sag assay: Ready for Prime time? yes Robert G Gish MD Professor Consultant, Stanford University Medical Director: Hepatitis B Foundation 1 Relevant Disclosures Consultant: Abbott, Genentech

More information

FRENCH NATIONAL PROGRAMME FOR PREVENTION AND CONTROL OF VIRAL HEPATITIS PRELIMINARY RESULTS. Patrick Marcellin

FRENCH NATIONAL PROGRAMME FOR PREVENTION AND CONTROL OF VIRAL HEPATITIS PRELIMINARY RESULTS. Patrick Marcellin FRENCH NATIONAL PROGRAMME FOR PREVENTION AND CONTROL OF VIRAL HEPATITIS PRELIMINARY RESULTS Patrick Marcellin Federation Nationale des Pôles de Référence et Reseaux Hépatites FNPRRH Hepatitis C in France

More information

Branch: Greece Director: Aris Antsaklis Established: Year 2004

Branch: Greece Director: Aris Antsaklis Established: Year 2004 Branch: Greece Director: Aris Antsaklis Established: Year 2004 The Greek branch of Ian Donald School was established in 2004 by Dr. ARIS ANTSAKLIS in Athens. The Greek school organizes a course on advanced

More information

MassEyeAndEar.org twitter.com/masseyeandear facebook.com/masseyeandearnews youtube.com/masseyeandear linkedin.com/company/mass-eye-and-ear

MassEyeAndEar.org twitter.com/masseyeandear facebook.com/masseyeandearnews youtube.com/masseyeandear linkedin.com/company/mass-eye-and-ear MassEyeAndEar.org twitter.com/masseyeandear facebook.com/masseyeandearnews youtube.com/masseyeandear linkedin.com/company/mass-eye-and-ear Mass. Eye and Ear clinicians and scientists are driven by a mission

More information

Hepatitis B Reactivation

Hepatitis B Reactivation Hepatitis B Reactivation IOM, December 1 st, 2015 Rohit Loomba, MD, MHSc Professor of Medicine, Division of Gastroenterology and Adjunct Professor, Division of Epidemiology University of California at

More information

4 th Annual conference on. gynecologic oncology. JULY 18-19, 2018 Atlanta, USA.

4 th Annual conference on. gynecologic oncology. JULY 18-19, 2018 Atlanta, USA. 4 th Annual conference on gynecologic oncology JULY 18-19, Atlanta, http://gynecologic-oncology.conferenceseries.com/ Invitation Dear Attendees, We are glad to announce the 4 th Annual Conference on Gynecologic

More information

Consultation Liaison Psychiatry Two Year Clinical Fellowship

Consultation Liaison Psychiatry Two Year Clinical Fellowship Consultation Liaison Psychiatry Two Year Clinical Fellowship This Fellowship is offered to candidates who have not had any psychiatry training in North America. Name of institution: McGill University Health

More information

Ronald D. Miller M.D., M.S.

Ronald D. Miller M.D., M.S. Ronald D. Miller M.D., M.S. The Pursuit of Excellence By James E. Caldwell, M.B., Ch.B. Introduction Ronald D. Miller, M.D. In October 2008 Dr. Ronald D. Miller received the prestigious Distinguished Service

More information

MANAGEMENT TOOLS FOR LARGE & EXPANDING ART CLINICS

MANAGEMENT TOOLS FOR LARGE & EXPANDING ART CLINICS MANAGEMENT TOOLS FOR LARGE & EXPANDING ART CLINICS 8th & 9th October 2015 Windsor, UK With the expansion and growth of IVF clinics comes new challenges. Gain insights and advice from experienced ART leaders

More information

Worldwide Causes of HCC

Worldwide Causes of HCC Approach to HCV Treatment in Patients with HCC Mark W. Russo, MD, MPH, FACG Carolinas HealthCare System Charlotte Worldwide Causes of HCC 60% 50% 40% 30% 20% 10% 0% 54% 31% 15% Hepatitis B Hepatitis C

More information

PCORI s Hepatitis C Workshop. Arlington, VA October 17, 2014

PCORI s Hepatitis C Workshop. Arlington, VA October 17, 2014 PCORI s Hepatitis C Workshop Arlington, VA October 17, 2014 1 Plenary Session: Review and Discussion of Prioritized CER Questions Eric B. Bass, MD Director, Johns Hopkins Evidence-based Practice Center

More information

Update on HIV-HCV Epidemiology and Natural History

Update on HIV-HCV Epidemiology and Natural History Update on HIV-HCV Epidemiology and Natural History Jennifer Price, MD Assistant Clinical Professor of Medicine University of California, San Francisco Learning Objectives Upon completion of this presentation,

More information

First Scientific Symposium Translational Research in Alzheimer. Paris - September 18, 2009 Collège de France

First Scientific Symposium Translational Research in Alzheimer. Paris - September 18, 2009 Collège de France First Scientific Symposium Translational Research in Alzheimer Paris - September 18, 2009 Collège de France 8h30 Welcome coffee 9h-9h30 Opening remarks - Philippe Lagayette, President of French National

More information

PROGRAMME. DAY 1 (Tuesday, 21 November 2017) Katowice - Poland. 12:45 13:15 How to write the Methods section lecture John Carpenter (UK)

PROGRAMME. DAY 1 (Tuesday, 21 November 2017) Katowice - Poland. 12:45 13:15 How to write the Methods section lecture John Carpenter (UK) DAY 1 (Tuesday, 21 November 2017) Katowice - Poland 09:00 09:15 Welcome [Piotr Knapik] 09:15-10:15 Introduction to the course John Carpenter (UK) 10:15 11:00 Clinical trial publications lecture John Carpenter

More information

Academic Critical Care Medicine. University of Alberta

Academic Critical Care Medicine. University of Alberta Academic Critical Care Medicine University of Alberta Established Specialty Critical Care Medicine now embodies a unique body of knowledge of the epidemiology, assessment, treatment and outcomes of critical

More information

HCV Elimination Mini Policy Summit Eliminating HCV in Greece Hosted by MEP Georgios Kyrtsos European Parliament, 22 November 2017, A5E-3, 10:00 12:00

HCV Elimination Mini Policy Summit Eliminating HCV in Greece Hosted by MEP Georgios Kyrtsos European Parliament, 22 November 2017, A5E-3, 10:00 12:00 HCV Elimination Mini Policy Summit Eliminating HCV in Greece Hosted by MEP Georgios Kyrtsos European Parliament, 22 November 2017, A5E-3, 10:00 12:00 Speakers biographies In order of appearance Georgios

More information

HEPAMAP: A ROADMAP FOR HEPATOLOGY RESEARCH IN EUROPE: AN OVERVIEW FOR POLICY MAKERS

HEPAMAP: A ROADMAP FOR HEPATOLOGY RESEARCH IN EUROPE: AN OVERVIEW FOR POLICY MAKERS HEPAMAP: A ROADMAP FOR HEPATOLOGY RESEARCH IN EUROPE: AN OVERVIEW FOR POLICY MAKERS HEPAMAP: A Roadmap For Hepatology Research In Europe: An Overview For Policy Makers Liver diseases are extremely costly

More information

Dr Rebecca Preston FRCP FRCR Consultant Radiologist Course Director Radiology Lead for Cardiac CT Guy s and St Thomas NHS Foundation Trust London, UK

Dr Rebecca Preston FRCP FRCR Consultant Radiologist Course Director Radiology Lead for Cardiac CT Guy s and St Thomas NHS Foundation Trust London, UK Speaker Biographies Dr Ronak Rajani MD FRCP FESC FSCCT Consultant Cardiologist Course Director Cardiology Lead for Cardiac CT Guy s and St Thomas NHS Foundation Trust London, UK Dr Rajani is the Founder

More information

Abraded and fractured dentition - Etiologies and treatment strategies

Abraded and fractured dentition - Etiologies and treatment strategies Abraded and fractured dentition - Etiologies and treatment strategies Full vs. Partial Coverage, Resins vs. Ceramics 16 February, 2016 Dan Panorama Hotel, Tel Aviv 18:30-22:30 Dr. Devorah Schwartz-Arad

More information

ITI. INNOVATIVE THERAPIES based on IMMUNOLOGY. July 1-3, 2013 Cordeliers Research Center Paris, France PRELIMINARY PROGRAMME

ITI. INNOVATIVE THERAPIES based on IMMUNOLOGY. July 1-3, 2013 Cordeliers Research Center Paris, France PRELIMINARY PROGRAMME Lorem Ipsum ITI INNOVATIVE THERAPIES based on IMMUNOLOGY 20 Fello wships availab le! & CME cre dits! July 1-3, 2013 Cordeliers Research Center Paris, France PRELIMINARY PROGRAMME This course is organized

More information

HBV Therapy in Special Populations: Liver Cirrhosis

HBV Therapy in Special Populations: Liver Cirrhosis HBV Therapy in Special Populations: Liver Cirrhosis Universitätsklinikum Leipzig Thomas Berg Sektion Hepatologie Klinik und Poliklinik für Gastroenterologie und Rheumatologie Leber- und Studienzentrum

More information

ALLERGY AND CLINICAL IMMUNOLOGY FELLOWSHIP PROGRAM DEPARTMENT OF PEDIATRICS

ALLERGY AND CLINICAL IMMUNOLOGY FELLOWSHIP PROGRAM DEPARTMENT OF PEDIATRICS ALLERGY AND CLINICAL IMMUNOLOGY FELLOWSHIP PROGRAM DEPARTMENT OF PEDIATRICS I. INTRODUCTION The Pediatric Allergy and Immunology (A&I) Fellowship Program at King Faisal Specialist Hospital and Research

More information

Hepatitis B: A Preventable Cause of Liver Cancer. Saira Khaderi MD, MPH Assistant Professor of Surgery Associate Director, Project ECHO June 17, 2016

Hepatitis B: A Preventable Cause of Liver Cancer. Saira Khaderi MD, MPH Assistant Professor of Surgery Associate Director, Project ECHO June 17, 2016 Hepatitis B: A Preventable Cause of Liver Cancer Saira Khaderi MD, MPH Assistant Professor of Surgery Associate Director, Project ECHO June 17, 2016 Overview Epidemiology HBV and cancer Screening, Diagnosis

More information

SUMMARY OF CURRICULUM VITAE LUIS SOUHAMI, MD

SUMMARY OF CURRICULUM VITAE LUIS SOUHAMI, MD SUMMARY OF CURRICULUM VITAE LUIS SOUHAMI, MD PERSONAL INFORMATION Date of birth: February 22, 1949 Marital status: Married, 2 children Place of birth: Vitoria, Brazil Citizenship: Brazilian, Canadian WORK

More information

Angelos Hatzakis. 10th Paris Hepatology Conference

Angelos Hatzakis. 10th Paris Hepatology Conference Angelos Hatzakis Professor of Epidemiology and Preventive Medicine Faculty of Medicine National and Kapodistrian University of Athens Co-Chair, Hepatitis B and C Public Policy Association 10th Paris Hepatology

More information

Merkin Brain and Health Policy Innovation Program 2013

Merkin Brain and Health Policy Innovation Program 2013 Merkin Brain and Health Policy Innovation Program 2013 Table of Contents Meet 2013 Fellow Daniella Meeker Research Spotlight on Alzheimer s Disease Meet 2013 Fellow Daniella Meeker 1 Research Spotlights:

More information

Advancing Hope: Pioneering Therapy for Rare Diseases

Advancing Hope: Pioneering Therapy for Rare Diseases Advancing Hope: Pioneering Therapy for Rare Diseases Friday, Feb. 19, 2016 8 a.m. to 6 p.m. John G. Rangos Sr. Conference Center Pittsburgh, PA Sponsored by the Center for Rare Disease Therapy at and the

More information

Inaugural Global Symposium May 17-19, 2018 Hilton Toronto Toronto, ON Canada

Inaugural Global Symposium May 17-19, 2018 Hilton Toronto Toronto, ON Canada Inaugural Global Symposium May 17-19, 2018 Hilton Toronto Toronto, ON Canada Effrat Habsha DDS, FRCD ARDII is designated as an Approved PACE Program Provider by the Academy of General Dentistry. The formal

More information

2016 Research Report

2016 Research Report Department of Internal Medicine 2016 Research Report Ted Mikuls, MD, MSPH, Vice Chairman of Research Department of Internal Medicine In this publication, you will find a summary of the Annual Research

More information

Update on Hepatitis C. Francesco Negro Hôpitaux Universitaires de Genève Berne, November 15, 2017

Update on Hepatitis C. Francesco Negro Hôpitaux Universitaires de Genève Berne, November 15, 2017 Update on Hepatitis C Francesco Negro Hôpitaux Universitaires de Genève Berne, November 15, 2017 The global prevalence of HCV was 1 0% (95% uncertainty interval 0 8 1 1) in 2015: 71 1 million (62 5 79

More information

Hepatitis B and Interferon Philippe Sogni Paris-Descartes University, INSERM U-1016 and Hepatology unit, Cochin hospital, Paris; France PHC 2015

Hepatitis B and Interferon Philippe Sogni Paris-Descartes University, INSERM U-1016 and Hepatology unit, Cochin hospital, Paris; France PHC 2015 Hepatitis B and Interferon Philippe Sogni Paris-Descartes University, INSERM U-1016 and Hepatology unit, Cochin hospital, Paris; France PHC 2015 1 Prof. Philippe SOGNI, M.D., Ph.D. Affiliations Institut

More information

Utility of HCV antigen core quantification for the screening of chronic hepatitis C

Utility of HCV antigen core quantification for the screening of chronic hepatitis C Utility of HCV antigen core quantification for the screening of chronic hepatitis C Karine LACOMBE - Léa Duchesne Inserm Unit UMR-S 1136, Team 2 Pierre Louis Institute of Epidemiology and Public Health

More information

ABOUT ADVANCES IN STROKE RECOVERY REGISTRATION

ABOUT ADVANCES IN STROKE RECOVERY REGISTRATION ABOUT ADVANCES IN STROKE RECOVERY Advances in Stroke Recovery is an annual meeting showcasing exciting new discoveries and research in stroke recovery. This year, the Heart and Stroke Foundation Canadian

More information

HCERES report on interdisciplinary unit:

HCERES report on interdisciplinary unit: Research units HCERES report on interdisciplinary unit: Laboratoire de Psychologie et NeuroCognition LPNC Under the supervision of the following institutions and research bodies: Université Pierre Mendès

More information

HEE Workforce Planning 2014/15 Call for Evidence

HEE Workforce Planning 2014/15 Call for Evidence HEE Workforce Planning 2014/15 Call for Evidence To submit your evidence please complete this form. Please make your submissions relevant to the categories provided in the boxes provided. We have categorised

More information

PRESENTATION TO INVESTORS. I attach a PowerPoint presentation as presented by Biotron Limited's CEO, Dr Michelle Miller, to investors today.

PRESENTATION TO INVESTORS. I attach a PowerPoint presentation as presented by Biotron Limited's CEO, Dr Michelle Miller, to investors today. Level 2, 66 Hunter Street Sydney NSW 2000 Tel: (61-2) 9300 3344 Fax: (61-2) 9221 6333 E-mail: pnightingale@biotron.com.au Website: www.biotron.com.au 11 November 2010 The Manager Companies ASX Limited

More information

8th Meet The Professor. Advanced International Breast Cancer Course (AIBCC)

8th Meet The Professor. Advanced International Breast Cancer Course (AIBCC) Sezione di Oncologia [ Meet the Professor ] 8th Meet The Professor. Advanced International Breast Cancer Course (AIBCC) November 15-17, 2012 The Conference will include: 1) Lectures: Internationally recognized

More information

Annual Scientific Meeting of the Australian Atherosclerosis Society

Annual Scientific Meeting of the Australian Atherosclerosis Society Annual Scientific Meeting of the Australian Atherosclerosis Society October 21 23, 2015, Fremantle, Western Australia Faculty Member Biographies International Guest Speakers: Prof. Bart Staels, Pasteur

More information

HepCure : An innovative web-based toolkit to support the treatment of hepatitis C at community health centers in New York State

HepCure : An innovative web-based toolkit to support the treatment of hepatitis C at community health centers in New York State HepCure : An innovative web-based toolkit to support the treatment of hepatitis C at community health centers in New York State CHCANYS 15: Statewide Conference & Clinical Forum October 19, 2015 Jeffrey

More information

Hepatitis C, Cured By Johnny Delirious

Hepatitis C, Cured By Johnny Delirious Hepatitis C, Cured By Johnny Delirious The Future of Hepatitis C Treatment - Healthline - Several hepatitis C treatments currently being researched. Learn about these potentially game-changing treatments,

More information

Together we ve achieved many successes. THE CH.I.L.D. FOUNDATION

Together we ve achieved many successes. THE CH.I.L.D. FOUNDATION Together we ve achieved many successes. THE CH.I.L.D. FOUNDATION Established 1995 Co-founders Grace McCarthy OC, OBC, Lindsay Gordon and Mary Parsons establish the Foundation for Children with Intestinal

More information

Curriculum Vitae. Professor Juan Carlos Kaski, DSc, DM (Hons), MD, FRCP, FESC,FAHA, FRSM. Present Position and Address. Training and Education

Curriculum Vitae. Professor Juan Carlos Kaski, DSc, DM (Hons), MD, FRCP, FESC,FAHA, FRSM. Present Position and Address. Training and Education Curriculum Vitae Professor Juan Carlos Kaski, DSc, DM (Hons), MD, FRCP, FESC,FAHA, FRSM Present Position and Address Professor of Cardiovascular Science, Molecular & Clinical Sciences Research Institute,

More information

TOLUCA, ESTADO DE MEXICO, MEXICO. OCTOBER

TOLUCA, ESTADO DE MEXICO, MEXICO. OCTOBER TOLUCA, ESTADO DE MEXICO, MEXICO. OCTOBER 2010. The World Cultural Council will celebrate the twentyseventh Award Ceremony on Wednesday December 8 th, at 11:00hrs, in the Universidad Autónoma del Estado

More information

Merkin Brain and Health Policy Innovation Program 2013

Merkin Brain and Health Policy Innovation Program 2013 Merkin Brain and Health Policy Innovation Program 2013 Table of Contents Meet 2013 Fellow Daniella Meeker Research Spotlight on Alzheimer s Disease Meet 2013 Fellow Daniella Meeker 1 Research Spotlights:

More information

HCERES report on research unit: Under the supervision of the following institutions and research bodies:

HCERES report on research unit: Under the supervision of the following institutions and research bodies: Research units HCERES report on research unit: Laboratoire de Biochimie-Nutrition Humaine Under the supervision of the following institutions and research bodies: Agrocampus Ouest - Institut Supérieur

More information

CIRROSI E IPERTENSIONE PORTALE NELLA DONNA

CIRROSI E IPERTENSIONE PORTALE NELLA DONNA Cagliari, 16 settembre 2017 CIRROSI E IPERTENSIONE PORTALE NELLA DONNA Vincenza Calvaruso, MD, PhD Ricercatore di Gastroenterologia Gastroenterologia & Epatologia, Di.Bi.M.I.S. Università degli Studi di

More information

Wellington is the capital of New Zealand and its activity is centred on government, as well as the creative industries.

Wellington is the capital of New Zealand and its activity is centred on government, as well as the creative industries. IABC Wellington: Membership Marketing work plan 2015 Context Wellington is the capital of New Zealand and its activity is centred on government, as well as the creative industries. IABC Wellington is a

More information

Appendix A: PROBABILITY OF INSECT TRANSMISSION

Appendix A: PROBABILITY OF INSECT TRANSMISSION Appendix A: PROBABILITY OF INSECT TRANSMISSION I. PROBABILITY OF MOSQUITO TRANSMISSION OF HIV, BASED ON HAMSTER ANIMAL MODEL FOR RIFT VALLEY FEVER VIRUS (RVFV): It is known that inoculation of less than

More information

Eliminating the Public Health Problem of Hepatitis B and C in the United States BOARD ON POPULATION HEALTH AND PUBLIC HEALTH PRACTICE

Eliminating the Public Health Problem of Hepatitis B and C in the United States BOARD ON POPULATION HEALTH AND PUBLIC HEALTH PRACTICE Eliminating the Public Health Problem of Hepatitis B and C in the United States Background on The National Academy of Medicine Established by Congress in 1970 as the Institute of Medicine of the National

More information

LCFA/IASLC LORI MONROE SCHOLARSHIP IN TRANSLATIONAL LUNG CANCER RESEARCH 2017 REQUEST FOR APPLICATION (RFA)

LCFA/IASLC LORI MONROE SCHOLARSHIP IN TRANSLATIONAL LUNG CANCER RESEARCH 2017 REQUEST FOR APPLICATION (RFA) LCFA/IASLC LORI MONROE SCHOLARSHIP IN TRANSLATIONAL LUNG CANCER RESEARCH FUNDING OPPORTUNITY DESCRIPTION 2017 REQUEST FOR APPLICATION (RFA) Lung Cancer Foundation of America (LCFA) and the International

More information

Cancer Science and Therapy

Cancer Science and Therapy 26 th Annual Congress on Cancer Science and Therapy Oct 03-04,, cancertherapy@cancersummit.org Invitation Dear Attendees, We are glad to announce the 26 th Annual Congress on Cancer Science and Therapy

More information

Neurofibromatosis (NF) Center

Neurofibromatosis (NF) Center Washington University Neurofibromatosis (NF) Center THE NF CENTER: EXCEPTIONAL CARE THROUGH GROUNDBREAKING RESEARCH An international leader in research and treatment of neurofibromatosis (NF), the Washington

More information

CNRC. Children s Nutrition Research Centre Brisbane, Australia. World class research into children s nutrition

CNRC. Children s Nutrition Research Centre Brisbane, Australia. World class research into children s nutrition CNRC Children s Nutrition Research Centre Brisbane, Australia World class research into children s nutrition Mission To improve the health of children and young people through scientific research and education

More information

DIVISION OF NEPHROLOGY & HYPERTENSION

DIVISION OF NEPHROLOGY & HYPERTENSION DIVISION OF NEPHROLOGY & HYPERTENSION DIVISION OF NEPHROLOGY & HYPERTENSION UH CASE MEDICAL CENTER Among the nation s leading academic medical centers, UH Case Medical Center is the primary affiliate of

More information

HBeAg-positve chronic hepatts B: Why do I treat my patent with a NA? Maria But

HBeAg-positve chronic hepatts B: Why do I treat my patent with a NA? Maria But HBeAg-positve chronic hepatts B: Why do I treat my patent with a NA? Maria But Hospital Universitario Valle Hebron and Ciberehd del Insttuto Carlos III. Barcelona. Spain Disclosures Advisory board of,

More information

Vasilis Vasiliou. Q. Max Guo. Alcohol and Cancer

Vasilis Vasiliou. Q. Max Guo. Alcohol and Cancer Alcohol and Cancer Samir Zakhari Editors Vasilis Vasiliou Q. Max Guo Alcohol and Cancer Editors Samir Zakhari, Ph.D. Director Division of Metabolism and Health Effects National Institute on Alcohol Abuse

More information

RAAT Rapid Access Model of Care in HCV

RAAT Rapid Access Model of Care in HCV RAAT Rapid Access Model of Care in HCV Marrianne Black CN Cheryl Sendall CNC Dr Caroline Tallis/Dr Rebecca Ryan Elizabeth Peat/Courtney Balk/Mirjana Palezevic AO Special thanks for the support and input

More information

General Assembly A new phase for paediatric clinical research: a role play for TEDDY? January 14 th, 2018 Hotel Ripa Via degli Orti di Trastevere, 3

General Assembly A new phase for paediatric clinical research: a role play for TEDDY? January 14 th, 2018 Hotel Ripa Via degli Orti di Trastevere, 3 General Assembly A new phase for paediatric clinical research: a role play for TEDDY? January 14 th, 2018 Hotel Ripa Via degli Orti di Trastevere, 3 Rome - Italy The TEDDY Network of Excellence arose from

More information

EUROPEAN HEART RHYTHM ASSOCIATION A Registered Branch of the ESC

EUROPEAN HEART RHYTHM ASSOCIATION A Registered Branch of the ESC Application for the following position in the EHRA Board: Treasurer 1. Your Identity Title: Prof., MD, PhD, FESC Family Name(s): Raatikainen First Name(s): Matti Jukka Pekka Birth Date: April 3, 1963 Type

More information

in pregnancy Document Review History Version Review Date Reviewed By Approved By

in pregnancy Document Review History Version Review Date Reviewed By Approved By GYNAECOLOGY/ ANTENATAL CARE WIRRAL WOMEN & CHILDREN S HOSPITAL Guideline No: Hepatitis B management in pregnancy VERSION 1 AMENDMENTS MADE: N/A DATE OF ISSUE: May 2012 DATE OF REVIEW: May 2015 REVIEW INTERVAL:

More information

Scientific committee and invited speakers

Scientific committee and invited speakers Scientific committee and invited speakers Scientific committee Philippe Robert (health domain) is professor of Psychiatry at the Nice School of Medicine, Director of the Nice Memory Centre for Care and

More information

Economic and societal impact of direct-acting antiviral therapy in Hepatitis C Zoltán Kaló

Economic and societal impact of direct-acting antiviral therapy in Hepatitis C Zoltán Kaló Economic and societal impact of directacting antiviral therapy in Hepatitis C Zoltán Kaló Professor of Health Economics ISPOR 19th Annual European Congress November 2 nd 2016 ATHCV16099925102016 Concerns

More information

PRESS RELEASE FOR IMMEDIATE RELEASE SINGAPORE INSTITUTES COLLABORATE WITH SAMSUNG MEDICAL CENTER TO IMPROVE TREATMENT OF LIVER CANCER

PRESS RELEASE FOR IMMEDIATE RELEASE SINGAPORE INSTITUTES COLLABORATE WITH SAMSUNG MEDICAL CENTER TO IMPROVE TREATMENT OF LIVER CANCER PRESS RELEASE FOR IMMEDIATE RELEASE SINGAPORE INSTITUTES COLLABORATE WITH SAMSUNG MEDICAL CENTER TO IMPROVE TREATMENT OF LIVER CANCER This collaboration creates the world s first clinically reliable and

More information

Prevention and control of viral hepatitis: Role and impact of liver patient groups in Europe. The Netherlands National hepatitis Centre

Prevention and control of viral hepatitis: Role and impact of liver patient groups in Europe. The Netherlands National hepatitis Centre Prevention and control of viral hepatitis: Role and impact of liver patient groups in Europe. The Netherlands National hepatitis Centre 1) History of the organisation(s) Founded in 1997 by: Dutch liver

More information

Hepatitis C - results in real life

Hepatitis C - results in real life Hepatitis C - results in real life Robert Flisiak Department of Infectious Diseases and Hepatology Medical University of Białystok, Poland 10th PHC Paris, 30-31 January 2017 Disclosures Advisor and/or

More information

American Cancer Society Research Programs

American Cancer Society Research Programs American Cancer Society Research Programs The American Cancer Society dedicates more money to cancer research than any other private, not-for-profit, non-government funder of cancer research in the United

More information

September 1, The Honorable Tom Price, MD Secretary Department of Health and Human Services 200 Independence Avenue SW Washington, DC 20201

September 1, The Honorable Tom Price, MD Secretary Department of Health and Human Services 200 Independence Avenue SW Washington, DC 20201 September 1, 2017 The Honorable Tom Price, MD Secretary Department of Health and Human Services 200 Independence Avenue SW Washington, DC 20201 Dear Secretary Price: The National Association of County

More information

EMORY UNIVERSITY SCHOOL OF MEDICINE STANDARD CURRICULUM VITAE FORMAT

EMORY UNIVERSITY SCHOOL OF MEDICINE STANDARD CURRICULUM VITAE FORMAT EMORY UNIVERSITY SCHOOL OF MEDICINE STANDARD CURRICULUM VITAE FORMAT Revised: October 1, 2012 Name: Greg Erens, M.D. Office Address: Emory Orthopaedics and Spine Center 59 Executive Park South Atlanta,

More information

CURICULUM VITAE. Premedical Year: Collage of Science, King Saud University, Riyadh, Saudi Arabia (September, July 1990)

CURICULUM VITAE. Premedical Year: Collage of Science, King Saud University, Riyadh, Saudi Arabia (September, July 1990) 1 CURICULUM VITAE Wael Al-Kattan, MD, FRCSC Associate Professor and Consultant Surgeon Hepatobiliary and Pancreatic Surgery and Liver Transplantation Minimally Invasive Surgery Alfaisal University P.O.Box

More information

Hepatitis B Virus infection: virology

Hepatitis B Virus infection: virology Hepatitis B Virus infection: virology 167 Falk Symposium: Liver under constant attack from fat to viruses III Falk Gastro-Konferenz 17.-21. September 2008 Congress Centrum Mainz Maura Dandri Department

More information

Karen E. Kim, MD Professor of Medicine Dean for Faculty Affairs Director, Center for Asian Health Equity University of Chicago

Karen E. Kim, MD Professor of Medicine Dean for Faculty Affairs Director, Center for Asian Health Equity University of Chicago Karen E. Kim, MD Professor of Medicine Dean for Faculty Affairs Director, Center for Asian Health Equity University of Chicago 1 2 billion people have been exposed to HBV 350-400 million people chronically

More information

Forward Looking Statements

Forward Looking Statements Antiviral Therapies Forward Looking Statements This presentation contains forward-looking statements, including the timing of our drug development programs. Risks include delays in manufacturing created

More information